Related Experiment Videos
NK-cell activity in immunotoxicity drug evaluation.
Karin Cederbrant1, Maritha Marcusson-Ståhl, Fabienne Condevaux
1Department of Molecular Toxicology/Immunotoxicology, Safety Assessment, AstraZeneca R&D Södertälje, SE-151 85, Södertälje, Sweden. karin.cederbrant@astrazeneca.com
Toxicology
|February 13, 2003
Summary
New flow-cytometric assays offer a sensitive, repeatable method for measuring natural killer (NK)-cell activity in rats. This approach aids in detecting drug-induced immunotoxicity, aligning with European regulatory guidance for drug safety testing.
Area of Science:
- Immunotoxicology
- Drug Safety Assessment
- Flow Cytometry
Background:
- European guidance (CPMP/SWP/1042/99) highlights NK-cell activity and lymphocyte subsets as alternatives to antibody response testing for drug immunotoxicity.
- These assays are recommended for routine inclusion in repeated dose-toxicity studies in rodents.
- The conventional method for assessing NK-cell activity is the 51Cr-release assay.
Purpose of the Study:
- To introduce and evaluate a novel flow-cytometric assay for measuring NK-cell activity in rat peripheral blood.
- To compare the sensitivity and practicality of the new assay against the standard 51Cr-release assay.
- To assess the utility of the flow-cytometric method for detecting drug-induced immunotoxicity.
Main Methods:
- Adaptation of a flow-cytometric assay for peripheral blood samples from rats.
- Measurement of NK-cell activity using the new flow-cytometric method.
- Comparison of results with the conventional 51Cr-release assay.
Main Results:
- The flow-cytometric assay does not necessitate separate animal groups, allowing for repeated testing on the same animals.
- The assay is demonstrated to be at least as sensitive as the traditional 51Cr-release assay.
- The method is suitable for routine use in toxicity studies.
Conclusions:
- A new flow-cytometric assay provides a sensitive and efficient alternative for assessing NK-cell activity in drug safety studies.
- This method facilitates repeated measurements and reduces animal usage compared to conventional assays.
- The assay is a valuable tool for detecting potential immunotoxic effects of new human drugs.